Article Menu

Export Article

More by Authors Links

Article Data

  • Views 45
  • Dowloads 7

This is a correction to: Signa Vitae. 2025; 21(1): 97-105. https://doi.org/10.22514/sv.2025.012

Corrections

Open Access

Correction: PRISMA-7 (for frailty assessment) and SARC-F (for evaluation of sarcopenia risk) in predicting emergency department readmission and mortality

  • Mehmet Cagri Goktekin1,*,
  • Evrim Gul1
  • Feyza Aksu2

1Department of Emergency Medicine, School of Medicine, Firat University, 23200 Elazig, Turkey

2Department of Anatomy, School of Medicine, Firat University, 23200 Elazig, Turkey

DOI: 10.22514/sv.2026.051 Vol.22,Issue 3,August 2026 pp.175-176

Published: 08 August 2026

*Corresponding Author(s): Mehmet Cagri Goktekin E-mail: mc.goktekin@firat.edu.tr

PDF (145.61 kB) View Full-text

Cite and Share

Goktekin MC, Gul E, Aksu F. Correction: PRISMA-7 (for frailty assessment) and SARC-F (for evaluation of sarcopenia risk) in predicting emergency department readmission and mortality. Signa Vitae. 2026; 22(3): 175-176. doi: 10.22514/sv.2026.051

URL:

https://www.signavitae.com/articles/10.22514/sv.2026.051

References

[1] Goktekin MC, Gul E, Aksu F. PRISMA-7 (for frailty assessment) and SARC-F (for evaluation of sarcopenia risk) in predicting emergency department readmission and mortality. Signa Vitae. 2025; 21: 97–105.

Submission Turnaround Time

Top